scispace - formally typeset
Open Access

ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Paulus Kirchhof, +3 more
- Vol. 70, Iss: 1, pp 1-84
About
The article was published on 2017-01-01 and is currently open access. It has received 3603 citations till now. The article focuses on the topics: Management of atrial fibrillation.

read more

Citations
More filters
Journal ArticleDOI

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

TL;DR: Authors/Task Force Members: Piotr Ponikowski* (Chairperson) (Poland), Adriaan A. Voors* (Co-Chair person) (The Netherlands), Stefan D. Anker (Germany), Héctor Bueno (Spain), John G. F. Cleland (UK), Andrew J. S. Coats (UK)
Journal ArticleDOI

2018 ESC/EACTS Guidelines on myocardial revascularization.

TL;DR: Authors/Task Force Members: Franz-Josef Neumann* (ESC Chairperson) (Germany), Miguel Sousa-Uva* (EACTS Chair person) (Portugal), Anders Ahlsson (Sweden), Fernando Alfonso (Spain), Adrian P. Banning (UK), Umberto Benedetto (UK).
Journal ArticleDOI

2017 HRS / EHRA / ECAS / APHRS / SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation

Hugh Calkins, +60 more
- 01 Oct 2017 - 
TL;DR: This 2017 Consensus Statement is to provide a state-of-the-art review of the field of catheter and surgical ablation of AF and to report the findings of a writing group, convened by these five international societies.
References
More filters
Journal ArticleDOI

Valsartan for Prevention of Recurrent Atrial Fibrillation

TL;DR: Treatment with valsartan was not associated with a reduction in the incidence of recurrent atrial fibrillation, and the results were similar in all predefined subgroups of patients, including those who were not receiving angiotensin-converting-enzyme inhibitors.
Journal ArticleDOI

Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial

TL;DR: The effects of both doses of dabigatran compared with warfarin were not significantly different between patients with previous stroke or transient ischaemic attack and those without for any of the outcomes from RE-LY apart from vascular death.
Journal ArticleDOI

Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention A Nationwide Cohort Study

TL;DR: High risk of bleeding is immediately evident with TT after myocardial infarction/percutaneous coronary intervention in patients with atrial fibrillation and TT should only be prescribed after thorough bleeding risk assessment of patients.
Journal ArticleDOI

Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry.

TL;DR: Left atrial appendage closure with the WATCHMAN device has a high success rate in complete LAAC with low peri-procedural risk, even in a population with a higher risk of stroke and bleeding, and multiple co-morbidities.
Journal ArticleDOI

Laboratory measurement of the anticoagulant activity of the non-vitamin K oral anticoagulants.

TL;DR: Dabigatran, rivaroxaban, and apixaban exhibit variable effects on coagulation assays and understanding these effects facilitates interpretation of test results in NOAC-treated patients.
Related Papers (5)